here is a list of biotech companies with emerging Head and Neck cancer Drugs Under Different Phases of Clinical Development
• CLR 131: Cellectar Biosciences, Inc.
• MEM-288: Memgen, Inc.
• IK 175: Ikena Oncology
• Tigilanol Tiglate: QBiotics Group Limited
• BNT 113: BioNTech
• Niraparib: GlaxoSmithKline
• Atezolizumab: Hoffmann-La Roche
• Xevinapant: Merck
extract from an article https://www.openpr.com/news/2891022/head-and-neck-cancer-pipeline-drugs-and-companies-insight-report
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-1013
-
- There are more pages in this discussion • 244 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online